萘普生和保泰松治疗强直性脊柱炎的双盲试验。
Double-blind trial of naproxen and phenylbutazone in ankylosing spondylitis.
作者信息
Van Gerwen F, Van der Korst J K, Gribnau F W
出版信息
Ann Rheum Dis. 1978 Feb;37(1):85-8. doi: 10.1136/ard.37.1.85.
Abstract
In a double-blind double-placebo crossover study naproxen (500-750 mg daily) was found to be equivalent to phenylbutazone (400-600 mg daily) in the control of disease activity in 20 patients suffering from ankylosing spondylitis during a two times 5-week trial period. No serious side effects were observed during the trial period. Gastric complaints occurred twice as often under phenylbutazone as under naproxen.
摘要
在一项双盲双安慰剂交叉研究中，发现在为期两周、每周5周的试验期内，萘普生（每日500 - 750毫克）在控制20例强直性脊柱炎患者的疾病活动方面与保泰松（每日400 - 600毫克）等效。试验期间未观察到严重副作用。保泰松组出现胃部不适的频率是萘普生组的两倍。
相似文献
1
Double-blind trial of naproxen and phenylbutazone in ankylosing spondylitis.萘普生和保泰松治疗强直性脊柱炎的双盲试验。
Ann Rheum Dis. 1978 Feb;37(1):85-8. doi: 10.1136/ard.37.1.85.
2
A comparative study of Butacote and Naprosyn in ankylosing spondylitis.布他考特与萘普生治疗强直性脊柱炎的对比研究。
Ann Rheum Dis. 1978 Oct;37(5):436-9. doi: 10.1136/ard.37.5.436.
3
A comparative study of Butacote and naproxen in ankylosing spondylitis.布他考特与萘普生治疗强直性脊柱炎的对比研究。
J Int Med Res. 1977;5 Suppl 2:95.
4
A comparison of diflunisal and phenylbutazone in the treatment of ankylosing spondylitis.双氟尼酸与保泰松治疗强直性脊柱炎的比较。
Clin Rheumatol. 1986 Jun;5(2):210-20. doi: 10.1007/BF02032359.
5
A comparison of flurbiprofen with naproxen in ankylosing spondylitis.
N Z Med J. 1980 Oct 22;92(670):309-11.
6
A double-blind cross-over trial of fenoprofen and phenylbutazone in ankylosing spondylitis.一项关于芬洛芬和保泰松治疗强直性脊柱炎的双盲交叉试验。
Rheumatol Rehabil. 1980 Nov;19(4):260-3. doi: 10.1093/rheumatology/19.4.260.
7
Double-bind cross-over tiral of flurbiprofen and phenylbutazone in ankylosing spondylitis.氟比洛芬与保泰松治疗强直性脊柱炎的双盲交叉试验
Br Med J. 1974 Nov 30;4(5943):496-9. doi: 10.1136/bmj.4.5943.496.
8
Ankylosing spondylitis: open long-term and double-blind crossover studies with naproxen.强直性脊柱炎：萘普生的开放性长期和双盲交叉研究
J Clin Pharmacol. 1975 Apr;15(4 Pt. 2):355-62. doi: 10.1002/j.1552-4604.1975.tb01464.x.
9
Double-blind study of ketoprofen and phenylbutazone in ankylosing spondylitis.酮洛芬与保泰松治疗强直性脊柱炎的双盲研究。
Rheumatol Rehabil. 1976;Suppl:37-42. doi: 10.1093/rheumatology/15.5.37.
10
Flurbiprofen in the treatment of ankylosing spondylitis. A comparison with phenylbutazone.
Am J Med. 1986 Mar 24;80(3A):120-6. doi: 10.1016/0002-9343(86)90128-2.
引用本文的文献
1
Pan American League of Associations for Rheumatology recommendations for the management of axial spondyloarthritis.泛美风湿病协会联盟关于治疗中轴型脊柱关节炎的建议。
Nat Rev Rheumatol. 2023 Nov;19(11):724-737. doi: 10.1038/s41584-023-01034-z. Epub 2023 Oct 6.
2
Non-steroidal anti-inflammatory drugs (NSAIDs) for axial spondyloarthritis (ankylosing spondylitis and non-radiographic axial spondyloarthritis).用于中轴型脊柱关节炎（强直性脊柱炎和非放射学中轴型脊柱关节炎）的非甾体抗炎药
Cochrane Database Syst Rev. 2015 Jul 17;2015(7):CD010952. doi: 10.1002/14651858.CD010952.pub2.
3
Information for physicians and pharmacists about drugs that might cause dry mouth: a study of monographs and published literature.关于可能导致口干的药物的医师和药剂师信息：专论和已发表文献的研究。
Drugs Aging. 2014 Jan;31(1):55-65. doi: 10.1007/s40266-013-0141-5.
4
Ankylosing spondylitis: an overview.强直性脊柱炎：概述
Ann Rheum Dis. 2002 Dec;61 Suppl 3(Suppl 3):iii8-18. doi: 10.1136/ard.61.suppl_3.iii8.
5
Current guidelines for the drug treatment of ankylosing spondylitis.强直性脊柱炎药物治疗的现行指南。
Drugs. 1998 Aug;56(2):225-40. doi: 10.2165/00003495-199856020-00006.
6
Antirheumatic drugs: clinical pharmacology and therapeutic use.抗风湿药物：临床药理学与治疗应用。
Drugs. 1980 Dec;20(6):453-84. doi: 10.2165/00003495-198020060-00002.
7
Ankylosing spondylitis. Current drug treatment.强直性脊柱炎。当前的药物治疗。
Drugs. 1992 Oct;44(4):585-603. doi: 10.2165/00003495-199244040-00006.
8
Naproxen up to date: a review of its pharmacological properties and therapeutic efficacy and use in rheumatic diseases and pain states.萘普生最新进展：对其药理特性、治疗效果以及在风湿性疾病和疼痛状态中的应用的综述。
Drugs. 1979 Oct;18(4):241-77. doi: 10.2165/00003495-197918040-00001.
本文引用的文献
1
Anti-inflammatory and analgetic properties of d-2-(6'-methoxy-2'-naphthyl)-propionic acid (naproxen).d-2-(6'-甲氧基-2'-萘基)丙酸（萘普生）的抗炎和镇痛特性。
J Pharmacol Exp Ther. 1971 Oct;179(1):114-23.
2
Assessment of the flexibility of the lumbar spine. A pilot study in children and adolescents.腰椎柔韧性评估。一项针对儿童和青少年的初步研究。
Scand J Rheumatol. 1973;2(2):87-91. doi: 10.3109/03009747309098823.
3
Naproxen. A new non-hormonal anti-inflammatory agent. Studies in rheumatoid arthritis.萘普生。一种新型非激素类抗炎药。类风湿关节炎研究。
Ann Rheum Dis. 1974 Jan;33(1):12-9. doi: 10.1136/ard.33.1.12.
4
Naproxen metabolism in man.萘普生在人体内的代谢
J Clin Pharmacol. 1975 Apr;15(4 Pt. 2):316-23. doi: 10.1002/j.1552-4604.1975.tb01458.x.
5
[A double blind comparison of naproxen and indomethacin on the after-midnight-pain of patients with morbus bechterew].萘普生与吲哚美辛对贝赫切特病患者午夜后疼痛的双盲比较
Arzneimittelforschung. 1975 Feb;25(2A):324-5.
6
Ankylosing spondylitis: open long-term and double-blind crossover studies with naproxen.强直性脊柱炎：萘普生的开放性长期和双盲交叉研究
J Clin Pharmacol. 1975 Apr;15(4 Pt. 2):355-62. doi: 10.1002/j.1552-4604.1975.tb01464.x.
7
Retardation of ossification of the lumbar vertebral column in ankylosing spondylitis by means of phenylbutazone.
Scand J Rheumatol. 1976;5(1):60-4.
8
Four new anti-inflammatory drugs: responses and variations.四种新型抗炎药物：反应与变化
Br Med J. 1976 May 1;1(6017):1048-9. doi: 10.1136/bmj.1.6017.1048.
Zotero 插件